136 related articles for article (PubMed ID: 12448692)
41. A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude.
Choi Y; George C; Comin MJ; Barchi JJ; Kim HS; Jacobson KA; Balzarini J; Mitsuya H; Boyer PL; Hughes SH; Marquez VE
J Med Chem; 2003 Jul; 46(15):3292-9. PubMed ID: 12852759
[TBL] [Abstract][Full Text] [Related]
42. [Ester derivatives of nucleoside inhibitors of reverse transcriptase: II. Molecular systems for combined therapy with 3'-azido-3'-deoxythymidine and 2',3'-didehydro-3'-deoxythymidine].
Berezovskaia IuV; Chudinov MV
Bioorg Khim; 2005; 31(5):451-65. PubMed ID: 16245688
[TBL] [Abstract][Full Text] [Related]
43. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite.
McGuigan C; Cahard D; Sheeka HM; De Clercq E; Balzarini J
J Med Chem; 1996 Apr; 39(8):1748-53. PubMed ID: 8648614
[TBL] [Abstract][Full Text] [Related]
44. Large-scale synthesis and formulation of GMP-grade stampidine, a new anti-HIV agent.
DuMez D; Venkatachalam TK; Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):136-51. PubMed ID: 16570822
[TBL] [Abstract][Full Text] [Related]
45. Enzymatically activated cycloSal-d4T-monophosphates: The third generation of cycloSal-pronucleotides.
Gisch N; Balzarini J; Meier C
J Med Chem; 2007 Apr; 50(7):1658-67. PubMed ID: 17335187
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and anti-HIV activity of 4'-cyano-2',3'-didehydro-3'-deoxythymidine.
Haraguchi K; Itoh Y; Takeda S; Honma Y; Tanaka H; Nitanda T; Baba M; Dutschman GE; Cheng YC
Nucleosides Nucleotides Nucleic Acids; 2004; 23(4):647-54. PubMed ID: 15200028
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
[TBL] [Abstract][Full Text] [Related]
48. Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives.
Venkatachalam TK; Samuel P; Qazi S; Uckun FM
Bioorg Med Chem; 2005 Sep; 13(18):5408-23. PubMed ID: 15994083
[TBL] [Abstract][Full Text] [Related]
49. cycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery system.
Meier C; Lorey M; De Clercq E; Balzarini J
J Med Chem; 1998 Apr; 41(9):1417-27. PubMed ID: 9554875
[TBL] [Abstract][Full Text] [Related]
50. Aryl-substituted and benzo-annulated cyc/osal-derivatives of 2',3'-dideoxy-2',3'-didehydrothymidine monophosphate--correlation of structure, hydrolysis properties and anti-HIV activity.
Ducho C; Balzarini J; Naesens L; De Clercq E; Meier C
Antivir Chem Chemother; 2002 Mar; 13(2):129-41. PubMed ID: 12238530
[TBL] [Abstract][Full Text] [Related]
51. beta-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL.
Zhang M; Huang Q; Huang Y; Wood O; Yuan W; Chancey C; Daniel S; Rios M; Hewlett I; Clouse KA; Dayton AI
Retrovirology; 2008 Sep; 5():82. PubMed ID: 18808673
[TBL] [Abstract][Full Text] [Related]
52. A new approach to the synthesis of 4'-carbon-substituted nucleosides: development of a highly active anti-HIV agent 2', 3'-didehydro-3'-deoxy-4'-ethynylthymidine.
Haraguchi K; Takeda S; Sumino M; Tanaka H; Dutschman GE; Cheng YC; Nitanda T; Baba M
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):343-7. PubMed ID: 16247949
[TBL] [Abstract][Full Text] [Related]
53. Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variation.
McGuigan C; Tsang HW; Cahard D; Turner K; Velazquez S; Salgado A; Bidois L; Naesens L; De Clercq E; Balzarini J
Antiviral Res; 1997 Aug; 35(3):195-204. PubMed ID: 9298759
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and anti-HIV evaluation of hybrid-type prodrugs conjugating HIV integrase inhibitors with d4t by self-cleavable spacers containing an amino acid residue.
Fossey C; Huynh NT; Vu AH; Vidu A; Zarafu I; Laduree D; Schmidt S; Laumond G; Aubertin AM
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):608-19. PubMed ID: 18035829
[TBL] [Abstract][Full Text] [Related]
55. Study of different substituted cyclic and acyclic benzylpronucleotides of d4T relative to their hydrolytic stability and antiviral activity.
Muus U; De Clercq E; Balzarini J; Naesens L; Meier C
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):791-5. PubMed ID: 14565280
[TBL] [Abstract][Full Text] [Related]
56. Anti-HIV activity of novel phosphonate derivatives of AZT, d4T, and ddA.
Pokrovsky AG; Pronayeva TR; Fedyuk NV; Shirokova EA; Khandazhinskaya AL; Tarusova NB; Karpenko IL; Krayevsky AA
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):767-9. PubMed ID: 11563112
[TBL] [Abstract][Full Text] [Related]
57. From the chemistry of epoxy-sugar nucleosides to the discovery of anti-HIV agent 4'-ethynylstavudine-Festinavir.
Haraguchi K; Takeda S; Kubota Y; Kumamoto H; Tanaka H; Hamasaki T; Baba M; Paintsil E; Cheng YC
Curr Pharm Des; 2013; 19(10):1880-97. PubMed ID: 23092278
[TBL] [Abstract][Full Text] [Related]
58. Bis-cycloSal-d4T-monophosphates: drugs that deliver two molecules of bioactive nucleotides.
Ducho C; Görbig U; Jessel S; Gisch N; Balzarini J; Meier C
J Med Chem; 2007 Mar; 50(6):1335-46. PubMed ID: 17328534
[TBL] [Abstract][Full Text] [Related]
59. "Lock-in" modified cyclosal nucleotides--the second generation of cyclosal prodrugs.
Vukadinović D; Böge NP; Balzarini J; Meier C
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):939-42. PubMed ID: 16248067
[TBL] [Abstract][Full Text] [Related]
60. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro.
Siccardi D; Gumbleton M; Omidi Y; McGuigan C
Eur J Pharm Sci; 2004 May; 22(1):25-31. PubMed ID: 15113580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
